Home/Filings/4/0001021771-23-000096
4//SEC Filing

ALSTODT LANCE 4

Accession 0001021771-23-000096

CIK 0001505497other

Filed

Sep 17, 8:00 PM ET

Accepted

Sep 18, 9:17 AM ET

Size

9.6 KB

Accession

0001021771-23-000096

Insider Transaction Report

Form 4
Period: 2023-09-15
ALSTODT LANCE
DirectorPresident, CEO, COB
Transactions
  • Purchase

    Common Stock

    2023-09-15$1.70/sh+2,200$3,740189,505 total
Holdings
  • Stock Option

    Exercise: $5.08Exp: 2031-03-18Common Stock (293,479 underlying)
    293,479
  • Stock Option

    Exercise: $5.08Exp: 2031-11-04Common Stock (42,059 underlying)
    42,059
  • Stock Option

    Exercise: $2.91Exp: 2033-02-17Common Stock (106,762 underlying)
    106,762
Footnotes (5)
  • [F1]This transaction was executed in multiple trades at prices ranging from $1.66 to $1.75 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected.
  • [F2]Includes 48,912 shares received pursuant to an unvested restricted stock unit grant. Such shares vest on March 18, 2024.
  • [F3]The option vests and becomes exercisable to the extent of 146,740 shares on March 18, 2021, 36,684 shares on November 4, 2021 and 110,055 shares in six nearly equal quarterly installments beginning December 18, 2021 and continuing every three months thereafter until fully vested.
  • [F4]The option vests and becomes exercisable to the extent of 21,030 shares on November 4, 2021 and 21,029 shares in eight nearly equal quarterly installments beginning November 4, 2022 and continuing every three months thereafter until fully vested.
  • [F5]The option vests and becomes exercisable to the extent of 53,381 shares on February 17, 2023 and 53,381 shares in eight nearly equal quarterly installments beginning February 17, 2024 and continuing every three months thereafter until fully vested.

Documents

1 file

Issuer

BioRestorative Therapies, Inc.

CIK 0001505497

Entity typeother

Related Parties

1
  • filerCIK 0001756228

Filing Metadata

Form type
4
Filed
Sep 17, 8:00 PM ET
Accepted
Sep 18, 9:17 AM ET
Size
9.6 KB